Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 15 open reading frame 62 (C15orf62) encodes a mitochondrial protein whose function has not been experimentally characterized. Bioinformatic predictions suggest roles in small GTPase binding, regulation of cell shape, Rho protein signal transduction, and actin filament polymerization, possibly implicating it in cytoskeletal and cellular signaling processes. Rare inherited and de novo genetic variants in C15orf62 have been observed in individuals with autism spectrum disorder, and statistical analyses indicate it may be an ASD candidate gene, but causality is not established and no mechanistic details are available. No interacting drugs, biomarkers, or established disease-modifying functions are reported. C15orf62 remains a poorly characterized and non-canonical target in both basic research and clinical contexts[1][5][12][14][15].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 15 open reading frame 62 (C15orf62).